205 related articles for article (PubMed ID: 30030625)
1. α-Tocopheryl succinate-suppressed development of cerebral malaria in mice.
Kume A; Kasai S; Furuya H; Suzuki H
Parasitol Res; 2018 Oct; 117(10):3177-3182. PubMed ID: 30030625
[TBL] [Abstract][Full Text] [Related]
2. Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.
Ariefta NR; Kume A; Nishikawa Y; Taniguchi T; Umemiya-Shirafuji R; Kasai S; Suzuki H
Acta Parasitol; 2022 Dec; 67(4):1514-1520. PubMed ID: 35951222
[TBL] [Abstract][Full Text] [Related]
3. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
4. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
5. Effect of α-tocopheryloxy acetic acid, a vitamin E derivative mitocan, on the experimental infection of mice with Plasmodium yoelii.
Kawamura K; Kume A; Umemiya-Shirafuji R; Kasai S; Suzuki H
Malar J; 2021 Jun; 20(1):280. PubMed ID: 34167535
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection.
Kume A; Herbas MS; Shichiri M; Ishida N; Suzuki H
Parasitol Res; 2016 Jan; 115(1):69-75. PubMed ID: 26358099
[TBL] [Abstract][Full Text] [Related]
7. Probucol-Induced α-Tocopherol Deficiency Protects Mice against Malaria Infection.
Herbas MS; Shichiri M; Ishida N; Kume A; Hagihara Y; Yoshida Y; Suzuki H
PLoS One; 2015; 10(8):e0136014. PubMed ID: 26296197
[TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
[TBL] [Abstract][Full Text] [Related]
9. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.
Shear HL; Marino MW; Wanidworanun C; Berman JW; Nagel RL
Am J Trop Med Hyg; 1998 Dec; 59(6):852-8. PubMed ID: 9886187
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
11. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
12. Evaluating experimental cerebral malaria using oxidative stress indicator OKD48 mice.
Imai T; Iwawaki T; Akai R; Suzue K; Hirai M; Taniguchi T; Okada H; Hisaeda H
Int J Parasitol; 2014 Sep; 44(10):681-5. PubMed ID: 24995619
[TBL] [Abstract][Full Text] [Related]
13. Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice.
Herbas MS; Ueta YY; Ichikawa C; Chiba M; Ishibashi K; Shichiri M; Fukumoto S; Yokoyama N; Takeya M; Xuan X; Arai H; Suzuki H
Malar J; 2010 Apr; 9():101. PubMed ID: 20403155
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria.
DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA
Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094
[TBL] [Abstract][Full Text] [Related]
15. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
16. Probucol dramatically enhances dihydroartemisinin effect in murine malaria.
Kume A; Anh DT; Shichiri M; Ishida N; Suzuki H
Malar J; 2016 Sep; 15():472. PubMed ID: 27634686
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
[TBL] [Abstract][Full Text] [Related]
18. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
19. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
[TBL] [Abstract][Full Text] [Related]
20. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
